Biogen to Acquire Apellis Pharmaceuticals in $5.6 Billion Deal
Biogen has announced plans to acquire Apellis Pharmaceuticals in a deal valued at $5.6 billion to expand its portfolio in […]
BIOGEN-WILL-PAY-41-PER-SHARE-IN-CASH
Biogen has announced plans to acquire Apellis Pharmaceuticals in a deal valued at $5.6 billion to expand its portfolio in […]
